Bristol Myers Squibb (BMY) Research & Development (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Research & Development of $2.96 billion in Q2 2026, up 14.7% from $2.58 billion a year earlier and up 11.7% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Research & Development (2009 - 2026) Analysis & Trends
On a TTM basis, Bristol Myers Squibb's Research & Development came in at $10.72 billion as of Jun 30, 2026, up 3.1% year-over-year; for FY2025, it was $9.95 billion, down 10.8% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $11.16 billion in FY2024 (+20.0%), $9.3 billion in FY2023 (-2.2%), $9.51 billion in FY2022 (-6.7%) and $10.2 billion in FY2021 (+1.5%).
- The Q2 2026 figure is the highest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development rose in five of the last eight quarters, with growth averaging 3.4%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 28.8% in Q4 2024, against a decline of 19.0% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.65 billion (Q1 2026), $2.59 billion (Q4 2025) and $2.53 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Bristol Myers Squibb | 126.07 Bn | 77.35 Bn | 9.25 Bn | 2.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Bn |
| Mar 31, 2026 | 2.65 Bn |
| Dec 31, 2025 | 2.59 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.58 Bn |
| Mar 31, 2025 | 2.26 Bn |
| Dec 31, 2024 | 3.19 Bn |
| Sep 30, 2024 | 2.37 Bn |
| Jun 30, 2024 | 2.90 Bn |
| Mar 31, 2024 | 2.70 Bn |
| Dec 31, 2023 | 2.48 Bn |
| Sep 30, 2023 | 2.24 Bn |
| Jun 30, 2023 | 2.26 Bn |
| Mar 31, 2023 | 2.32 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Sep 30, 2022 | 2.42 Bn |
| Jun 30, 2022 | 2.32 Bn |
| Mar 31, 2022 | 2.26 Bn |
| Dec 31, 2021 | 2.52 Bn |
| Sep 30, 2021 | 2.98 Bn |
API Access
Bristol Myers Squibb Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();